Our Board of Directors provides strategic leadership aligned to AusBiotech’s long held vision, to be the leading Australian industry body representing and advocating for organisations doing business in and with the global life sciences economy. AusBiotech’s Board guides the organisation’s strategic direction and governance, shaping sustainable long term growth. Our Board is comprised of nine leaders, including the Chair and the CEO.
- Dr James Campbell, Chair, Prescient Therapeutics Ltd; Chair, AusBiotech
- Erica Bremner Kneipp, Research Director for the Human Health program, CSIRO; Deputy Chair, AusBiotech
- Dr Megan Baldwin, Non-Executive Director, Racura Oncology
- Dr Dean Moss, CEO, UniQuest Pty Ltd
- Dr Marthe D’Ombrain, Head of Global Research Innovation, CSL Limited
- Professor John Skerritt AM, Enterprise Professor in Health Research Impact, University of Melbourne
- Dr Liz Dallimore, CEO & Managing Director, Argenica Therapeutics Ltd
- Dr Dell Kingsford Smith, VP, Medical Affairs, Market Access & Government Affairs, Cochlear
- Rebekah Cassidy, CEO & Managing Director, AusBiotech